Biberach, Germany

Rainer Soyka

USPTO Granted Patents = 16 



Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1994-2013

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: Rainer Soyka: Innovator in Amino Crotonyl Compounds and Betamimetics

Introduction

Rainer Soyka, an accomplished inventor based in Biberach, Germany, holds an impressive portfolio of 16 patents. His work primarily focuses on the development of innovative processes related to pharmaceutical compounds, showcasing his significant contributions to the field of biochemistry.

Latest Patents

Among Rainer's latest patents is a groundbreaking process for preparing amino crotonyl compounds. This invention details an improved method for synthesizing 4-[(3-chloro-4-fluorophenyl)amino]-6-{[4-(N,N-dimethylamino)-1-oxo-2-buten-1-yl]amino}-7-((S)-tetrahydrofuran-3-yloxy)-quinazoline and related aminocrotonyl compounds. Additionally, it outlines the preparation of a suitable salt of this compound for usage as a pharmaceutically active substance. Another significant patent focuses on a process for the manufacturing of betamimetics, which are essential for developing various therapeutics.

Career Highlights

Rainer Soyka's professional journey is marked by his tenure at leading companies in the pharmaceutical industry. He has worked with Boehringer Ingelheim International GmbH and Dr. Karl Thomae GmbH, where he honed his expertise and made substantial contributions to pharmaceutical innovations.

Collaborations

Throughout his career, Rainer has collaborated with notable colleagues, including Johannes M. Weisenberger and Thomas Muller. Their partnerships have fostered the development of cutting-edge research and advancements in medicinal chemistry.

Conclusion

With a robust portfolio of patents and a successful career in the pharmaceutical sector, Rainer Soyka stands out as a prominent inventor. His innovative processes for amino crotonyl compounds and betamimetics represent significant advancements in drug development, reinforcing his impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…